TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 0 | -2 | -6 | 37 | 46 | -7 | 14 |
| P | %wins | 50 | 0 | 0 | 50 | 100 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/18 19:44 | 4/23/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Iv, L.P. | CA | T | S | -5,169 | 50.68 | 0 | -102 | -47 | 117 | I | |||||||||||||||
12/23/16 18:03 | 10/24/16 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Iv, L.P. | CA | T | P.ad | 2,254 | 14.00 | 1 | 161 | 79 | I | 19 | 6 | 3 | -2 | 1 | -3 | -10 | -13 | ||||||||
11/17/11 19:05 | 11/16/11 | CLVS | Clovis Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Iv, L.P. | CA | T | P.d | 0 | 0.00 | 24 | 665 | 14 | I | -1 | -1 | -2 | 86 | 46 | -7 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |